Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (8866)	7/27/2003 11:36:25 PM
From: Biomaven	Read Replies (1) \| Respond to of 52153

<Ron Garren - GLFD> I also bought a (very) little GLFD not that long ago given that it hasn't participated much in the rally but it has some interesting prospects. Propofol is approved for conscious sedation in some countries, but I think it is not used for this indication in the US - typically Versed is used instead. (Anyone please correct me if I am wrong). In general, I suspect conscious sedation is a more difficult indication than true anesthesia - the people using it are not anesthesiologists and can screw up more easily. There are reimbursement issues as well: gastro.org Versed also needs to be titrated because of variable PK. To my surprise (given how widely used it is) it has a black box warning: rocheusa.com Peter